These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15504980)

  • 21. Glomerular structural changes in type 1 (insulin-dependent) diabetes mellitus: causes, consequences, and prevention.
    Osterby R
    Diabetologia; 1992 Sep; 35(9):803-12. PubMed ID: 1397774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural involvement in type 1 and type 2 diabetic nephropathy.
    Dalla Vestra M; Saller A; Bortoloso E; Mauer M; Fioretto P
    Diabetes Metab; 2000 Jul; 26 Suppl 4():8-14. PubMed ID: 10922968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal findings and glomerular pathology in diabetic subjects.
    Wirta O; Helin H; Mustonen J; Kuittinen E; Savela T; Pasternack A
    Nephron; 2000 Mar; 84(3):236-42. PubMed ID: 10720894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aldose reductase gene polymorphisms and susceptibility to diabetic nephropathy in Type 1 diabetes mellitus.
    Moczulski DK; Scott L; Antonellis A; Rogus JJ; Rich SS; Warram JH; Krolewski AS
    Diabet Med; 2000 Feb; 17(2):111-8. PubMed ID: 10746480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
    Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
    Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic deficiency of aldose reductase counteracts the development of diabetic nephropathy in C57BL/6 mice.
    Liu H; Luo Y; Zhang T; Zhang Y; Wu Q; Yuan L; Chung SS; Oates PJ; Yang JY
    Diabetologia; 2011 May; 54(5):1242-51. PubMed ID: 21267539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotypic heterogeneity and associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes: response to Wang et al.
    P K Ng D; Chia KS; Koh D
    Diabetes Care; 2004 Jan; 27(1):289-90; author reply 290. PubMed ID: 14694018
    [No Abstract]   [Full Text] [Related]  

  • 28. Diabetic nephropathy is not associated with the dinucleotide repeat polymorphism upstream of the aldose reductase (ALR2) gene but with erythrocyte aldose reductase content in Japanese subjects with type 2 diabetes.
    Maeda S; Haneda M; Yasuda H; Tachikawa T; Isshiki K; Koya D; Terada M; Hidaka H; Kashiwagi A; Kikkawa R
    Diabetes; 1999 Feb; 48(2):420-2. PubMed ID: 10334324
    [No Abstract]   [Full Text] [Related]  

  • 29. Variants in the gene encoding aldose reductase (AKR1B1) and diabetic nephropathy in American Indians.
    Wolford JK; Yeatts KA; Red Eagle AR; Nelson RG; Knowler WC; Hanson RL
    Diabet Med; 2006 Apr; 23(4):367-76. PubMed ID: 16620264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetic nephropathy. A perspective.
    Mauer SM; Steffes MW; Goetz FC; Sutherland DE; Brown DM
    Diabetes; 1983 May; 32 Suppl 2():52-5. PubMed ID: 6400668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats.
    Okada M; Takemura T; Yanagida H; Yoshioka K
    Kidney Int; 2002 Jan; 61(1):113-24. PubMed ID: 11786091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural and functional changes in diabetic glomerulopathy.
    Schleicher E; Kolm V; Ceol M; Nerlich A
    Kidney Blood Press Res; 1996; 19(5):305-15. PubMed ID: 8956243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction between the polyol pathway and non-enzymatic glycation on mesangial cell gene expression.
    Dan Q; Wong RL; Yin S; Chung SK; Chung SS; Lam KS
    Nephron Exp Nephrol; 2004; 98(3):e89-99. PubMed ID: 15528949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal pathology patterns in type II diabetes mellitus: relationship with retinopathy. The Collaborative Study Group.
    Schwartz MM; Lewis EJ; Leonard-Martin T; Lewis JB; Batlle D
    Nephrol Dial Transplant; 1998 Oct; 13(10):2547-52. PubMed ID: 9794557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of diabetic nephropathy in a transgenic model of hypoinsulinemic diabetes.
    Kanetsuna Y; Hirano K; Nagata M; Gannon MA; Takahashi K; Harris RC; Breyer MD; Takahashi T
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1315-22. PubMed ID: 16705146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcription Factor Egr1 is Involved in High Glucose-Induced Proliferation and Fibrosis in Rat Glomerular Mesangial Cells.
    Wang D; Guan MP; Zheng ZJ; Li WQ; Lyv FP; Pang RY; Xue YM
    Cell Physiol Biochem; 2015; 36(6):2093-107. PubMed ID: 26279418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aldose reductase inhibition and glomerular abnormalities in diabetic rats.
    Daniels BS; Hostetter TH
    Diabetes; 1989 Aug; 38(8):981-6. PubMed ID: 2502460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.
    Marchant V; Droguett A; Valderrama G; Burgos ME; Carpio D; Kerr B; Ruiz-Ortega M; Egido J; Mezzano S
    Am J Physiol Renal Physiol; 2015 Sep; 309(6):F559-68. PubMed ID: 26155842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aldose reductase (AC)n gene polymorphism and susceptibility to diabetic retinopathy in Type 2 diabetes in Caucasians.
    Petrovic MG; Peterlin B; Hawlina M; Petrovic D
    J Diabetes Complications; 2005; 19(2):70-3. PubMed ID: 15745835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated activity of transcription factor nuclear factor of activated T-cells 5 (NFAT5) and diabetic nephropathy.
    Yang B; Hodgkinson AD; Oates PJ; Kwon HM; Millward BA; Demaine AG
    Diabetes; 2006 May; 55(5):1450-5. PubMed ID: 16644704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.